|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 409/10 | |
| A61K 31/381 | |||
| A61P 3/00 |
| (11) | Patento numeris | 2994468 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14724380.2 |
| Europos patento paraiškos padavimo data | 2014-05-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-07-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/059281 |
| Data | 2014-05-07 |
| (87) | Numeris | WO 2014/180872 |
| Data | 2014-11-13 |
| (30) | Numeris | Data | Šalis |
| 13166940 | 2013-05-08 | EP | |
| 14155190 | 2014-02-14 | EP |
| (72) |
SELIC, Lovro, SI
HOTTER, Andreas, AT
LANGES, Christoph, AT
GRIESSER, Ulrich, AT
|
| (73) |
LEK Pharmaceuticals d.d.,
Verovskova 57, 1526 Ljubljana,
SI
|
| (54) | CRYSTALLINE HYDRATES OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE |
| CRYSTALLINE HYDRATES OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE |